Competition prompts drug companies to cut antiretroviral drug prices.
H
H
Ashraf
D000480:Alkynes; D019380:Anti-HIV Agents / Q000191:economics / Q000627:therapeutic use*; D048588:Benzoxazines; D003521:Cyclopropanes; D004345:Drug Industry; D017850:Economics, Pharmaceutical; D006801:Humans; D019469:Indinavir / Q000191:economics / Q000627:therapeutic use; D010078:Oxazines / Q000191:economics / Q000627:therapeutic use; D014481:United States
D000480:Alkynes; D019380:Anti-HIV Agents; D048588:Benzoxazines; D003521:Cyclopropanes; D010078:Oxazines; D019469:Indinavir; C098320:efavirenz